CEL-SCI Corp. (CVM)
6.60
-0.06
(-0.90%)
USD |
NYAM |
Dec 10, 16:00
6.60
0.00 (0.00%)
After-Hours: 16:55
CEL-SCI Cash from Investing (Quarterly): 0.00 for June 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | 0.296M |
| IGC Pharma, Inc. | -0.374M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Protalix Biotherapeutics, Inc. | -0.504M |
| Palatin Technologies, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.940M |
| Cash from Financing (Quarterly) | 3.808M |
| Free Cash Flow | -17.36M |
| Free Cash Flow Per Share (Quarterly) | -0.9492 |
| Free Cash Flow to Equity (Quarterly) | -3.372M |
| Free Cash Flow to Firm (Quarterly) | -3.768M |
| Free Cash Flow Yield | -4.83% |